+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Worldwide Organ on a Chip (OOC) Market [by Segments (Devices, Services); by Types (Lung, Heart, Liver, Intestine, Kidney, Human, Placenta, Gut, Nerve, Others); by Regions (North America, Europe, APAC, CALA, MEA)]: Sizes and Forecasts (2020 - 2025)

  • ID: 4455792
  • Report
  • August 2020
  • Region: Global, North America, Europe, Asia Pacific
  • 96 Pages
  • Arcluster
Organs-on-Chips: A $1 Billion Market in the Next Decade

FEATURED COMPANIES

  • 4Dcell
  • Cherry Biotech SAS
  • Elvesys
  • HµREL
  • Hesperos
  • Mimetas
  • MORE
The report on the Organ-on-a-Chip market provides an in-depth analysis of the market size, forecasts, and opportunities of Organ-on-a-Chip catering to the multiple key segments – Lung-on-Chip, Heart-on-Chip, Liver-on-Chip, Intestine-on-Chip, Kidney-on-Chip, Human-on-Chip, Placenta-on-Chip, Brain-on-Chip, Gut-on-Chip, Nerve-on-Chip, Others. The study also includes market analysis of Organ-on-a-Chip segments across five regions – North America, Europe, Asia-Pacific, Central and Latin America (CALA), and Middle-East and Africa (MEA).

This Organ-on-a-Chip market report also includes insights into key market requirements gathered from scientists, medical professionals, bioengineers, researchers, biotechnology companies, pharmaceutical, cosmetics and chemical companies. The report also provides their preferences, priorities, and perception of adoption of Organ-on-a-Chip across regions. The analysis in this report will help market participants, vendors, suppliers, distributors, and resellers to develop strategies, marketing goals and business decisions based on the actionable market intelligence from this report.

This report has been built on a rigorous period of information gathering from both secondary and primary sources through several interviews with industry participants, technology developers, and regulators. Data gathered from these interviews and surveys was curated, analyzed, and engineered to understand buying, spending, demand, and supply patterns and to estimate market sizes and forecasts. The resultant data was checked for applicability across value chains through market-data associations and then further validated through multiple check points to check consistencies, error samples, variances. The 2018 syndicated study report on the Organ-on-a-Chip market is part of an ongoing series of market reports that focus on micro emerging trends in the healthcare markets across multiple regions and countries.

Questions answered in the report
  • What is the current size of the market?
  • What is the market opportunity for technologies?
  • What are the companies in this space and what do they offer?
  • What are the perceptions of technologies among users?
  • How ready is the market for new technologies and solutions?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 4Dcell
  • Cherry Biotech SAS
  • Elvesys
  • HµREL
  • Hesperos
  • Mimetas
  • MORE
1. Organ on a Chip Market Research Overview
1.1 Research Design
1.1.1 Research Goals
1.1.2 Research Scope
1.1.3 Research Methodology
1.1.4 Market Assumptions
1.2 Executive Summary
1.3 Market Overview and Forces
1.3.1 Market Definition
1.3.2 Market Segmentation
1.3.3 Market Forces
1.3.3. a Drivers, Restraints, Challenges, and Opportunities (DRCOs)
1.3.3. b Impact Analysis of DRCOs

2. Market Size and Forecasts by Segments
2.1 Market Overview
2.2 Tools
2.3 Services

3. Market Size and Forecasts by Types
3.1 Market Overview
3.2 Lung-on-Chip
3.3 Heart-on-Chip
3.4 Liver-on-Chip
3.5 Intestine-on-Chip
3.6 Kidney-on-Chip
3.7 Human-on-Chip
3.8 Placenta-on-Chip
3.9 Brain-on-Chip
3.10 Gut-on-Chip
3.11 Nerve-on-Chip
3.12 Others

4. Market Size and Forecasts by Regions
4.1 Regional Overview
4.2 North America
4.3 Europe
4.4 Asia-Pacific
4.5 Central America/Latin America
4.6 Middle East and Africa (MEA)

List of Tables
Table 1: Forecast Assumptions and Growth Factors
Table 2: Impact Analysis of DRCOs
Table 3: Organ-on-a-Chip Market Participants and Key Products
Table 4: Organ-on-a-Chip Market Size and Forecast
Table 5: Organ-on-a-Chip Market Size and Forecast By Types
Table 6: Organ-on-a-Chip Market Size and Forecast, By Devices, by Regions
Table 7: Organ-on-a-Chip Market Size and Forecast, By Services, by Regions
Table 8: Organ-on-a-Chip Market Size and Forecast, By Segments
Table 9: Market Size and Forecast, By Lung-on-Chip, by Regions
Table 10: Market Size and Forecast, By Heart-on-Chip, by Regions
Table 11: Market Size and Forecast, By Liver-on-Chip, by Regions
Table 12: Market Size and Forecast, By Intestine-on-Chip, by Regions
Table 13: Market Size and Forecast, By Kidney-on-Chip, by Regions
Table 14: Market Size and Forecast, By Human-on-Chip, by Regions
Table 15: Market Size and Forecast, By Placenta-on-Chip, by Regions
Table 16: Market Size and Forecast, By Brain-on-Chip, by Regions
Table 17: Market Size and Forecast, By Gut-on-Chip, by Regions
Table 18: Market Size and Forecast, By Nerve-on-Chip, by Regions
Table 19: Market Size and Forecast, By Others, by Regions
Table 20: Organ-on-a-Chip Market Size and Forecast, by Regions
Table 21: North America Market Size and Forecast, By Types
Table 22: North America Market Size and Forecast, by Segments
Table 23: Europe Market Size and Forecast, By Types
Table 24: Europe Market Size and Forecast, by Segments
Table 25: APAC Market Size and Forecast, By Types
Table 26: APAC Market Size and Forecast, by Segments
Table 27: CALA Market Size and Forecast, By Types
Table 28: CALA Market Size and Forecast, by Segments
Table 29: MEA Market Size and Forecast, By Types
Table 30: MEA Market Size and Forecast, by Segments

List of Figures
Figure 1: Organ-on-a-Chip Market Research Methodology
Figure 2: Organ-on-a-Chip Market Segmentation
Figure 3: Organ-on-a-Chip Market Forces
Figure 4: Organ-on-a-Chip Market Size and Forecast
Figure 5: Organ-on-a-Chip Market Size and Forecast By Types
Figure 6: Organ-on-a-Chip Market Size and Forecast, By Devices
Figure 7: Organ-on-a-Chip Market Size and Forecast, By Services
Figure 8: Organ-on-a-Chip Market Size and Forecast, by Segments
Figure 9: Market Size and Forecast, By Lung-on-Chip, by Regions
Figure 10: Market Size and Forecast, By Heart-on-Chip, by Regions
Figure 11: Market Size and Forecast, By Liver-on-Chip, by Regions
Figure 12: Market Size and Forecast, By Intestine-on-Chip, by Regions
Figure 13: Market Size and Forecast, By Kidney-on-Chip, by Regions
Figure 14: Market Size and Forecast, By Human-on-Chip, by Regions
Figure 15: Market Size and Forecast, By Placenta-on-Chip, by Regions
Figure 16: Market Size and Forecast, By Brain-on-Chip, by Regions
Figure 17: Market Size and Forecast, By Gut-on-Chip, by Regions
Figure 18: Market Size and Forecast, By Nerve-on-Chip, by Regions
Figure 19: Market Size and Forecast, By Others, by Regions
Figure 20: Organ-on-a-Chip Market Size and Forecast, by Regions
Figure 21: North America Market Size and Forecast, By Types
Figure 22: North America Market Size and Forecast, by Segments
Figure 23: Europe Market Size and Forecast, By Types
Figure 24: Europe Market Size and Forecast, by Segments
Figure 25: APAC Market Size and Forecast, By Types
Figure 26: APAC Market Size and Forecast, by Segments
Figure 27: CALA Market Size and Forecast, By Types
Figure 28: CALA Market Size and Forecast, by Segments
Figure 29: MEA Market Size and Forecast, By Types
Figure 30: MEA Market Size and Forecast, by Segments
Note: Product cover images may vary from those shown

Loading
LOADING...

FEATURED COMPANIES

  • 4Dcell
  • Cherry Biotech SAS
  • Elvesys
  • HµREL
  • Hesperos
  • Mimetas
  • MORE

Drug and pharmaceutical companies lose billions of dollars due to high drug failure rates in clinical trials, largely due to the current limitations of using animal models and static cell culture systems. Coupled with this is the fact that the in-vitro modeling and therapy development for many diseases is not accurate. This creates a direct need for clinical modeling that is physiologically relevant to human organs and at the same time intuitively integrating human-derived cells with sensor-driven OOC systems.

However, complexities of organ functions aren’t easy to model. Creating an OOC system is a complicated process with multiple hurdles to cross. Firstly, there is a major need to accurately reproduce the architectural complexity of organs and tissues in vitro. Then, there is a bigger need to accurately link them in the correct format for the connected systems to recapitulate tissue-organ interactions. Solving this is set to be industry’s key priority. OOCs provide tremendous potential if commercialization is aided by collaborative efforts across the value-chain and ecosystem. Regulators, medical professionals, scientists, technicians, and organizations need to collaborate to usher in the future of medicine through OOCs.

Challenges aside, OOCs offer a possible opportunity to replace current animal based testing and assessments over time. However, it is unlikely that OOCs are comprehensive enough to make that change during the forecast period due to the traditional regulatory requirements and complexities of organ functions. The current forecast period is the earliest phase of market adoption for organ-on-a-chip players. The next decade is a favorable period for upward trend in regulation, ratification, and adoption. The use of OOCs, as a viable alternative to traditional clinical lab options, in an improving regulatory environment and increasing marketplace acceptance, promises to lay the foundation of the future of accurate medicine.

OOCs are a key piece in the future of personalized medicine, and collaborative efforts across the ecosystem are key to ensure widespread adoption. The market opportunity for Organ-on-a-Chip across the globe is considerable overall.

Note: Product cover images may vary from those shown
  • 4Dcell
  • AxoSim Techologies LLC
  • CN Bio Innovations
  • Cherry Biotech SAS
  • Elvesys
  • Emulate
  • Hepregen
  • Hesperos
  • HµREL
  • Insphero
  • Micronit Microtechnologies B.V.
  • Mimetas
  • Nortis
  • Organovo Holdings Inc.
  • Sophion Bioscience
  • Tara Biosystems
  • thinXXS Microtechnology AG
  • TissUse
Note: Product cover images may vary from those shown
Adroll
adroll